rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Remus Pharmaceuticals Ltd. - Research Center
Group () BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Half yearly results in brief
(Rs crore)
Sep ' 23 Sep ' 22
Sales 29.04 20.48
Operating profit 9.27 4.81
Interest 0.10 0.03
Gross profit 10.83 5.63
EPS (Rs) 53.01 37.52
Half yearly  results in details
Sep ' 23 Sep ' 22
Other income 1.66 0.85
Stock adjustment -0.85 1.08
Raw material - -
Power and fuel - -
Employee expenses 3.29 1.91
Excise - -
Admin and selling expenses - -
Research and development expenses - -
Expenses capitalised - -
Other expenses 17.33 12.67
Provisions made - -
Depreciation 0.42 0.09
Taxation 2.60 1.47
Net profit / loss 7.81 4.07
Extra ordinary item - -
Prior year adjustments - -
Equity capital 1.47 1.09
Equity dividend rate - -
Agg.of non-prom. shares (Lacs) - -
Agg.of non promotoholding (%) - -
OPM (%) 31.91 23.48
GPM (%) 35.28 26.41
NPM (%) 25.43 19.09
Close
Add Remus Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Remus Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close